Cancer

The latest cancer news from UNC Health Care and the UNC School of Medicine.

UNC Lineberger researchers identify DNA repair enzyme as a potential brain cancer drug target

UNC Lineberger researchers identify DNA repair enzyme as a potential brain cancer drug target

In the journal Cell Reports, UNC Lineberger researchers report that when they removed Dicer from preclinical models of medulloblastoma, a common type of brain cancer in children, they found high levels of DNA damage in the cancer cells, leading to the cells’ death.

UNC Lineberger researchers identify DNA repair enzyme as a potential brain cancer drug target - Read More…

Liquid Metal ‘Nano-Terminators’ Target Cancer Cells

Liquid Metal ‘Nano-Terminators’ Target Cancer Cells

The new cancer drug delivery system improved efficacy of standard chemotherapy for ovarian cancer in mice with limited toxicity.

Liquid Metal ‘Nano-Terminators’ Target Cancer Cells - Read More…

False-positive mammograms may indicate increased risk of breast cancer

False-positive mammograms may indicate increased risk of breast cancer

Findings suggest that radiologists studying mammograms observed suspicious markers that could have been indications of future cancer development.

False-positive mammograms may indicate increased risk of breast cancer - Read More…

UNC School of Medicine Names Inaugural Yang Family Biomedical Scholars

UNC School of Medicine Names Inaugural Yang Family Biomedical Scholars

The award, made possible through a donation from Lenovo chairman and CEO Yuanqing Yang, recognizes the research achievements of young tenured faculty.

UNC School of Medicine Names Inaugural Yang Family Biomedical Scholars - Read More…

UNC Lineberger-led study finds higher vitamin D and calcium intake does not reduce colorectal polyp risk

UNC Lineberger-led study finds higher vitamin D and calcium intake does not reduce colorectal polyp risk

A UNC Lineberger-led study published in the New England Journal of Medicine found that vitamin D and calcium supplements do not reduce the risk of colorectal adenomas, which are benign tumors that can evolve into colorectal cancer.

UNC Lineberger-led study finds higher vitamin D and calcium intake does not reduce colorectal polyp risk - Read More…

And Then There Were Two . . .

And Then There Were Two . . .

From aspiring soccer star to world-renowned biochemist, Aziz Sancar, MD, PhD, joined Carolina’s other Nobel Laureate, Oliver Smithies, PhD, during a celebration of science at the UNC School of Medicine.

And Then There Were Two . . . - Read More…

UNC Cancer: Lifting Patients Up

UNC Cancer: Lifting Patients Up

In the recent U.S. News and World Report rankings of America’s Best Hospitals, UNC Hospitals was nationally ranked in five of the 16 specialties. In this series, we profile these specialties to learn more about what makes them so outstanding.

UNC Cancer: Lifting Patients Up - Read More…

Scientists disguise drugs as platelets to target cancer cells

Scientists disguise drugs as platelets to target cancer cells

The new drug-creation method could allow cancer drugs to last longer in the body to attack tumors, as well as cancer cells floating in the blood stream.

Scientists disguise drugs as platelets to target cancer cells - Read More…

A Daughter’s Calling

A Daughter’s Calling

A science class captured Catherine Fahey’s imagination. A mother’s battle with cancer led her to pursue medicine as a career. At UNC, Fahey found a home at the junction of research and patient care.

A Daughter’s Calling - Read More…

Balancing Benefits and Harms: UNC Aims to Get Lung Cancer Screening Right

Balancing Benefits and Harms: UNC Aims to Get Lung Cancer Screening Right

When it comes to meeting the challenge of implementing new lung cancer screening guidelines, UNC is taking a multidisciplinary approach. Led by Daniel S. Reuland, MD MPH, Division of General Internal Medicine and Clinical Epidemiology, the UNC project on Supporting Appropriate Implementation of Lung cancer Screening (SAILS) is bringing together institutional experts as well as patient stakeholders to find ways to realize the benefits while minimizing the harms of the newly recommended screening test for lung cancer.

Balancing Benefits and Harms: UNC Aims to Get Lung Cancer Screening Right - Read More…

UNC Lineberger to partner in $12 million effort to find treatments for genetically-linked cancers

UNC Lineberger to partner in $12 million effort to find treatments for genetically-linked cancers

UNC Lineberger Comprehensive Cancer Center researchers and eight other leading cancer research institutions have won a five-year, $12 million grant to try to find treatments for a group of cancers linked to mutations in the NF1 gene.

UNC Lineberger to partner in $12 million effort to find treatments for genetically-linked cancers - Read More…

Researchers from UNC Lineberger, Norway launch cancer genetics collaboration

Researchers from UNC Lineberger, Norway launch cancer genetics collaboration

Researchers from Norway visited the cancer center last week to learn firsthand about UNCseq, a clinical trial launched in 2011 at the N.C. Cancer Hospital. In the trial, researchers use a profile of the genetic and molecular alterations in patients' tumors to try to identify targeted treatments for them.

Researchers from UNC Lineberger, Norway launch cancer genetics collaboration - Read More…

UNC-Chapel Hill researchers awarded $11.3 million for cancer nanotechnology research

UNC-Chapel Hill researchers awarded $11.3 million for cancer nanotechnology research

An $11.3 million, five-year grant from the National Cancer Institute will fund four studies by researchers with the Carolina Center of Cancer Nanotechnology Excellence.

UNC-Chapel Hill researchers awarded $11.3 million for cancer nanotechnology research - Read More…

Pancreatic cancer subtypes discovered in largest gene expression analysis of the disease to-date

Pancreatic cancer subtypes discovered in largest gene expression analysis of the disease to-date

A UNC Lineberger-led study, published today in Nature Genetics, paves the way for potential personalized medicine approaches for the deadly cancer type.

Pancreatic cancer subtypes discovered in largest gene expression analysis of the disease to-date - Read More…

Liam Canard receives his wish: a backyard batting cage

Liam Canard receives his wish: a backyard batting cage

Fourteen-year-old star baseball player Liam Canard, of Raleigh, has been playing baseball throughout his battle with Hodgkin's lymphoma. Yesterday, thanks to Make-A-Wish of Eastern North Carolina, Liam received a gift that will help him hone his hitting while also taking his mind off his journey with cancer, and local media was there to cover it. View and read our wrap-up of media coverage, which includes Liam, his family, and pediatric hematologist-oncologist Dr. Patrick Thompson.

Liam Canard receives his wish: a backyard batting cage - Read More…

Biomedical engineer Zhen Gu, PhD, tabbed as top young innovator

Biomedical engineer Zhen Gu, PhD, tabbed as top young innovator

The editors of the MIT Technology Review highlighted Gu’s work on a novel way to monitor and treat diabetes.

Biomedical engineer Zhen Gu, PhD, tabbed as top young innovator - Read More…

Landmark study validates method for patient reporting of cancer drug-related adverse events

Landmark study validates method for patient reporting of cancer drug-related adverse events

In an article published in JAMA Oncology today, a study led by UNC Lineberger's Ethan Basch and colleagues shows that a system they developed accurately and reliably captures the patient experience with cancer drug side effects.

Landmark study validates method for patient reporting of cancer drug-related adverse events - Read More…

Comprehending Chemotaxis

Comprehending Chemotaxis

James Bear, PhD, uncovers the intricate mechanisms that allow certain cells to move, discoveries with implications for cancer metastasis.

Comprehending Chemotaxis - Read More…

Share This: